Products
API
Our API - USA Portfolio** consists of the following:
| Therapeutic Category | Name of API | Regulatory Status |
|---|---|---|
| USDMF | ||
| Anti-cancer | Anastrazole (NM) | √ |
| Afatinib dimaleate | * | |
| Bicalutamide (NC) | √ | |
| Belinostat | * | |
| Bortezomib | -- | |
| Busulfan | * | |
| Cabazitaxel | -- | |
| Carboplatin | -- | |
| Carfilzomib | * | |
| Decitabine | * | |
| Docetaxel Trihydrate | -- | |
| Docetaxel anhydrous | * | |
| Erlotinib | -- | |
| Gefitinib | -- | |
| Gemcitabine HCl | √ | |
| Gemcitabine HCI (Alternate process) | -- | |
| Irinotecan HCl | * | |
| Ibrutinib | * | |
| Letrozole | * | |
| Oxaliplatin | √ | |
| Paclitaxel | √ | |
| Pemetrexed Diacid | -- | |
| Ribociclib | * | |
| Bendamustine | * | |
| Alectinib HCl | * | |
| Plerixafor | * | |
| Imatinib Mesylate | -- | |
| Neuromuscular Reversal Drug | Sugammadex | * |
| Anaesthetics | Bupivacaine | @ |
| Levobupivacaine | -- | |
| Ropivacaine (Alternate process) | * | |
| √ Granted * Filed @ To be filed – Not filed | ||
**The buyer / customer should make their independent evaluation of the patent scenario for their respective markets, in respect of the API/formulations bought from Fresenius Kabi Oncology Limited, and they shall be solely and exclusively responsible for all patent related liabilities including any litigation by third party.
